Cite
Dysregulation of the miRNome unveils a crosstalk between obesity and prostate cancer: miR-107 asa personalized diagnostic and therapeutic tool
MLA
Vicente Herrero-Aguayo, et al. “Dysregulation of the MiRNome Unveils a Crosstalk between Obesity and Prostate Cancer: MiR-107 Asa Personalized Diagnostic and Therapeutic Tool.” Molecular Therapy: Nucleic Acids, vol. 27, no. 1164–1178, Mar. 2022, pp. 1164–78. EBSCOhost, https://doi.org/10.1016/j.omtn.2022.02.010.
APA
Vicente Herrero-Aguayo, Prudencio Sáez-Martínez, Juan M. Jiménez-Vacas, M. Trinidad Moreno-Montilla, Antonio J. Montero-Hidalgo, Jesús M. Pérez-Gómez, Juan L. López-Canovas, Francisco Porcel-Pastrana, Julia Carrasco-Valiente, Francisco J. Anglada, Enrique Gómez-Gómez, Elena M. Yubero-Serrano, Alejandro Ibañez-Costa, Aura D. Herrera-Martínez, André Sarmento-Cabral, Manuel D. Gahete, & Raúl M. Luque. (2022). Dysregulation of the miRNome unveils a crosstalk between obesity and prostate cancer: miR-107 asa personalized diagnostic and therapeutic tool. Molecular Therapy: Nucleic Acids, 27(1164–1178), 1164–1178. https://doi.org/10.1016/j.omtn.2022.02.010
Chicago
Vicente Herrero-Aguayo, Prudencio Sáez-Martínez, Juan M. Jiménez-Vacas, M. Trinidad Moreno-Montilla, Antonio J. Montero-Hidalgo, Jesús M. Pérez-Gómez, Juan L. López-Canovas, et al. 2022. “Dysregulation of the MiRNome Unveils a Crosstalk between Obesity and Prostate Cancer: MiR-107 Asa Personalized Diagnostic and Therapeutic Tool.” Molecular Therapy: Nucleic Acids 27 (1164–1178): 1164–78. doi:10.1016/j.omtn.2022.02.010.